Global Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics (Lateral Flow Assays, ELISA), Molecular Diagnostics), Animal (Companion, Food-Producing), End-User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities), By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2015-2025

2019-11-01
Report Code: BWC19327
Available Format: PDF PDF Icon
Pages: 125

Global Veterinary Infectious Disease Diagnostics Market: Overview

Information or diagnosis of infectious diseases that can spread between animals - or even between animals and humans is basic to the field of veterinary drugs. The diagnostic of veterinary infectious diseases is known as veterinary infectious disease diagnostic. These diagnostics are commonly used to control human health indirectly. Monitoring and control of zoonotic disease, an infectious disease transmitted from animals to humans, food safety sanitation, and in a roundabout way through human applications from fundamental restorative research nourishment supply are through domesticated animals well-being observing and treatment, and psychological well-being by keeping pet's solid and long-living.

Global Veterinary Infectious Disease Diagnostics Market Forecast and Trends

The veterinary infectious disease diagnostics market anticipated reaching significant growth, with a considerable CAGR of 8.2%. Rising technological advancement in diagnostic devices, automation, rising companion animal population coupled with the increasing trend of pet insurance is the key factor anticipated to propel the demand of veterinary infectious disease diagnostics market in the forecast period of 2019-2025. Also, rising investment in animal healthcare, increasing incidence of zoonotic diseases trend, rising disposable income in emerging economies coupled with veterinary practitioner's enhancement contributing simultaneously to drive the global veterinary infectious disease diagnostics and expected to witness commendable growth in upcoming years.

Growth Drivers

Growing demand for advanced diagnostic devices

Rising demand and adoption of advanced veterinary infectious disease diagnostic technologies by professionals and practitioners for routine diagnostic such as nucleic acid diagnostics, biosensors, PCR, and biomarkers driving the market growth and anticipated to witness the positive impact on the growth in upcoming years 2019-2025.

Increasing Disease Control and Disease Prevention Measures

Rising animal healthcare expenditure by government authorities, increasing healthcare infrastructure coupled with strict regulatory & policy reforms, raise the demand for proper veterinary infectious disease diagnostic. The favorable regulatory scenario for approval of diagnostics contributing to driving growth in upcoming years. Investment in animal healthcare R&D for innovative product & technology advancement also anticipated witnessing a surge in demand for in-house diagnostic tools and techniques.

Restraint

Increasing Pet Care Costs

Rising technological advancement & strict regulatory policy & reforms indirectly leads to the rising costs associated with pet care in existing & upcoming market trends and expected to hamper the growth of the global veterinary infectious disease diagnostic market during the forecast period of 2019-2025.

Global Veterinary Infectious Disease Diagnostics Market: Technology

Based on technology, the global veterinary infectious disease diagnostics market seggregated into immunodiagnostics and molecular diagnostics. The immunodiagnostics further segmented into lateral flow assays, Elisa tests, and other immunodiagnostic technologies. The molecular diagnostics segment is further categorized into the polymerase chain reaction (PCR) tests, microarrays, and other molecular diagnostic tests. The rising emergence rate of advanced immunoassay formats and diagnostics contributing a major share to propel the growth of the immunodiagnostics segment in the global veterinary infectious disease diagnostic market during the forecast period of 2019-2025. Advantages associated with advanced technologies such as quick, sensitive & accurate diagnosis, high rate of efficacy, and accurate result validation coupled with the rising incidence of infectious diseases are anticipated to support the growth in upcoming years.

Global Veterinary Infectious Disease Diagnostics Market: Animal Type

On the basis of animal type, the global veterinary infectious disease diagnostics market segmented into companion animals and food-producing animals. The key factor to drive the growth of companion animal segment in the global market is highly transmittable nature of the viral disease. Rising bacterial infection and worm infestation incidences contribute to dominate the demand of the companion animal segment in the global veterinary infectious disease diagnostic market during the forecast period of 2019-2025.

Global Veterinary Infectious Disease Diagnostics Market: End-User

On the basis of the end-user, the global veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes & universities. The huge sample testing in reference laboratories from small and large animal practices driving the growth of the reference segment in the market in the upcoming years 2019-2025 with a significant growth rate. Hospitals and clinics are simultaneously contributing significantly to the market due to the first preference to contact animal owners for first point care.


Global Veterinary Infectious Disease Diagnostics Market: Regional Insights

Amidst geography, North America is expected to hold the largest share in the veterinary infectious disease diagnostics market, followed by Europe due to factors viz. the favorable scenario of healthcare structure in the region. Rising healthcare infrastructure, and expenditure on animal health and presence of leading players in the segment also pushed growth in the region. Also, rising companion animal ownership coupled with favorable animal health policies anticipated as the key factor for driving the demand of global veterinary infectious disease diagnostic market during the forecast period of 2019-2025. Emerging economies such as China, India, creating a positive impact on the growth of veterinary infectious disease diagnostics market with factors such as the increasing adoption of advanced products, rising demand of disease diagnostics in food-producing animals associated with zoonotic diseases incidences.

The Objective of the Study:

·         To analyze and forecast the global veterinary infectious disease diagnostics market size of the market, in terms of value.

·      To examine the careful market segmentation and forecast the market size, in terms value, based on the region by segmenting the global veterinary infectious disease diagnostics market into five regions, namely, North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their leading countries.

·         To outline, categorized and forecast the global veterinary infectious disease diagnostics market based on the type, application and end user.

·      To examine competitive developments like technological advancement, services, and regulative framework within the global veterinary infectious disease diagnostics market.

·         To highlight the impact analysis of the factors, affecting the market dynamics such as drivers, restraints, opportunities, and challenges.

·        To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

Scope of the Report

By Technology

·         Immunodiagnostics

o    Lateral Flow Assays

o    ELISA Tests

o    Other Immunodiagnostic Technologies

·         Molecular Diagnostics

o    Polymerase Chain Reaction (PCR) Tests

o    Microarrays

o    Other Molecular Diagnostic Tests

By Animal Type

         Companion Animals

         Food Producing Animals

By Disease Type

         Infectious Diseases

         Non-infectious Diseases

         Hereditary, Congenital, and Acquired Diseases

         General Ailments

         Structural and Functional Diseases

By End User

         Reference Laboratories

         Veterinary Laboratories and Clinics

         Point of Care / In House Testing

         Research Institutes and Universities

 By Region:

         North America

         Europe

         Asia Pacific

         Latin America

         Middle East & Africa

Competitive Landscape

         Biomerieux S.A.

         Heska Corporation

         IDEXX Laboratories, Inc.

         IDVet

         Neogen Corporation

         QIAGEN N.V. (A Part of Indical Bioscience)

         Randox Laboratories, Ltd.

         Thermo Fisher Scientific

         Virbac

         Zoetis, Inc.

         Other Prominent Players

Business Questions Answer by the Report

         How will the market drivers, restraints and opportunities affect the market dynamics?

         What will be the market size in terms of value and volume and market statistics with a detailed classification?

         Which segment dominates the market or region and one will be the fastest growing and why?

         A comprehensive survey of the competitive landscape and the market participant players.

         Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority and that’s why BlueWeave Consulting offers customization according to company’s specific needs. The following customization options are available for the report:

Additional Company Information

         With five additional company detail analysis

         Additional country analysis

         Detailed segment analysis

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Veterinary Infectious Disease Diagnostics Market - Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunities

4.1.4.   Challenges

4.2. Technological Landscape

4.3. Regulatory Framework

4.4. Company Market Share Analysis,2018

4.5. Porter’s Five Forces Analysis

4.6. Pest Analysis

4.7. Strategic Outlook

5.    Global Veterinary Infectious Disease Diagnostics Market Overview

5.1. Market Size & Forecast

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast, 2015 – 2025

5.2.1.   By Technology

5.2.1.1.1.           Immunodiagnostics

5.2.1.1.1.1.              Lateral Flow Assays

5.2.1.1.1.2.              ELISA Tests

5.2.1.1.1.3.              Other Immunodiagnostic Technologies

5.2.1.1.2.           Molecular Diagnostics

5.2.1.1.2.1.              Polymerase Chain Reaction (PCR) Tests

5.2.1.1.2.2.              Microarrays

5.2.1.1.2.3.              Other Molecular Diagnostic Tests

5.2.2.   By Animal Type

5.2.2.1.       Companion Animals

5.2.2.2.       Food Producing Animals

5.2.3.   By Disease Type

5.2.3.1.       Infectious Diseases

5.2.3.2.       Non-infectious Diseases

5.2.3.3.       Hereditary, Congenital, and Acquired Diseases

5.2.3.4.       General Ailments

5.2.3.5.       Structural and Functional Diseases

5.2.4.   By End User

5.2.4.1.       Reference Laboratories

5.2.4.2.       Veterinary Laboratories and Clinics

5.2.4.3.       Point of Care / In House Testing

5.2.4.4.       Research Institutes and Universities

5.2.5.   By Region

5.2.5.1.       North America

5.2.5.2.       Europe

5.2.5.3.       Asia-Pacific

5.2.5.4.       Latin America

5.2.5.5.       Middle East and Africa

6.    North America Veterinary Infectious Disease Diagnostics Market

6.1. Market Estimates & Forecast, 2015 - 2025

6.1.1.   By Technology

6.1.2.   By Animal Type

6.1.3.   By Disease Type

6.1.4.   By End User

6.1.5.   By Country

6.1.5.1.       U.S

6.1.5.2.       Canada

7.    Europe Veterinary Infectious Disease Diagnostics Market

7.1. Market Estimates & Forecast, 2015 - 2025

7.1.1.   By Technology

7.1.2.   By Animal Type

7.1.3.   By Disease Type

7.1.4.   By End User

7.1.5.   By Country

7.1.5.1.       Germany

7.1.5.2.       U.K

7.1.5.3.       France

7.1.5.4.       Italy

7.1.5.5.       Rest of Europe

8.    Asia-Pacific Veterinary Infectious Disease Diagnostics Market

8.1. Market Estimates & Forecast, 2015 - 2025

8.1.1.   By Technology

8.1.2.   By Animal Type

8.1.3.   By Disease Type

8.1.4.   By End User

8.1.5.   By Country

8.1.5.1.       China

8.1.5.2.       India

8.1.5.3.       Japan

8.1.5.4.       Rest of APAC

9.    Latin America Veterinary Infectious Disease Diagnostics Market

9.1. Market Estimates & Forecast, 2015 - 2025

9.1.1.   By Technology

9.1.2.   By Animal Type

9.1.3.   By Disease Type

9.1.4.   By End User

9.1.5.   By Country

9.1.5.1.       Brazil

9.1.5.2.       Argentina

9.1.5.3.       Rest of Latin America

10. Middle East & Africa Veterinary Infectious Disease Diagnostics Market

10.1.             Market Estimates & Forecast, 2015 - 2025

10.1.1. By Technology

10.1.2. By Animal Type

10.1.3. By Disease Type

10.1.4. By End User

10.1.5. By Country

10.1.5.1.    Saudi Arabia

10.1.5.2.    UAE

10.1.5.3.    South Africa

10.1.5.4.    Rest of MEA  

11. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

11.1.             Biomerieux S.A.

11.2.             Heska Corporation

11.3.             IDEXX Laboratories, Inc.

11.4.             IDVet

11.5.             Neogen Corporation

11.6.             QIAGEN N.V. (A Part of Indical Bioscience)

11.7.             Randox Laboratories, Ltd.

11.8.             Thermo Fisher Scientific

11.9.             Virbac

11.10.          Zoetis, Inc.

11.11.          Other Prominent Player

12. Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.

Need Help

Send Enquiry